NASDAQ · Biotechnology

Histogen Inc. (HSTO) Stock

$0.02 NASDAQ: HSTO Healthcare

Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform.

Valuation

MetricValue
Price$0.02
Market Cap$85435
P/E Ratio-0.01
P/B Ratio0.01
P/S Ratio0.02
EPS (TTM)$-3.46
52-Week High$0.02
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.67%
ROA-55.69%
ROCE-59.66%
Gross Margin100.00%
Operating Margin-282.38%
Net Margin-281.80%
Debt/Equity0.32
Current Ratio10.90

Annual Financials (USD)

Metric20182019202020212022
Revenue$34.0M$11.0M$2.0M$1.0M$4.0M
Operating Profit$-18.0M$-12.0M$-12.0M$-15.0M$-11.0M
Net Profit$-18.0M$-11.0M$-19.0M$-15.0M$-11.0M
EPS$-118.60$-5.02$-41.60$-7.51$-3.46
Op Margin-54.4%-104.8%-568.9%-1681.9%-282.4%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$49.0M$3.0M$15.0M$27.0M$19.0M
Total Liabilities$21.0M$41.0M$8.0M$7.0M$6.0M
Cash$12.0M$2.0M$7.0M$19.0M$12.0M
Borrowings$0$0$5.0M$5.0M$5.0M

Latest News

Tenet Healthcare (THC) Reports Earnings Tomorrow: What To Expect StockStory · Jul 23, 2026 Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026 GE Vernova’s AI power trade has one weak link TheStreet · Jul 23, 2026 Flagstar Financial Earnings: What To Look For From FLG StockStory · Jul 23, 2026 Eni and KazMunayGas Reach Key Milestone at Kazakhstan Hybrid Power Plant Oilprice.com · Jul 23, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-35.0M$-1.0M$-12.0M$-15.0M$-10.0M
Investing Cash Flow$30.0M$29.0M$22.0M$-1.0M$0
Financing Cash Flow$0$0$0$6.0M$-1.0M
Net Cash Flow$-5.0M$-1.0M$5.0M$12.0M$-7.0M
Free Cash Flow$-35.0M$-1.0M$-12.0M$-15.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.70
FCF Yield-11586.59%
Quick Ratio10.90
Interest Coverage-10643.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALRNAileron Therapeutics, Inc. $2.11 +9.33% -1.11 $45.72M 0.00%
ARTL $0.77 +1.96% -0.12 $1.80M 0.00%
BLCMBellicum Pharmaceuticals, Inc. $0.07 -6.68% -0.09 $778326 0.00%
BTTXBetter Therapeutics, Inc. $0.00 — 0.00 $5452 0.00%
BXRXBaudax Bio, Inc. $0.02 +0.00% 0.00 $0 0.00%

About Histogen Inc.

Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.

Histogen Inc. is headquartered in US.

Histogen Inc. (HSTO) stock trades at $0.02 with a market capitalization of $85435. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.01, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.02 and $0.02, and currently trades at its 52-week high.

On profitability, Histogen Inc. generates a return on equity (ROE) of -59.67%, return on capital employed of -59.66%, an operating margin of -282.38%, a net profit margin of -281.80%.

Official website: www.histogen.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides